Caribou Biosciences attends BioConnect Investor Conference in New York next week

Caribou Biosciences attends BioConnect Investor Conference in New York next week
Caribou Biosciences joins NY BioConnect

Caribou Biosciences announced that it will participate in the 4th Annual BioConnect Investor Conference hosted by H.C. Wainwright in New York City next week.

The event brings together leading cell therapy and biotechnology firms, researchers, and investors to discuss advancements and investment opportunities in the sector. Caribou Biosciences is expected to showcase its work in CRISPR-based cell therapies as it seeks engagement with key stakeholders. Details on the company's agenda at the conference and planned presentations have not been specified. Details are being clarified.

Caribou Biosciences has recently maintained an active conference schedule. CEO Rachel Haurwitz was featured at the BofA Securities Health Care Conference in Las Vegas to discuss biotech advances. She also participated in a fireside chat webcast at a Bank of America event. The company continues to engage with investors and industry stakeholders through these appearances.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.